Tuesday, July 7, 2026
ADVT 
National

Lululemon says Omicron impacting sales, profits

Darpan News Desk The Canadian Press, 10 Jan, 2022 04:54 PM
  • Lululemon says Omicron impacting sales, profits

VANCOUVER - Lululemon Athletica Inc. is lowering its fourth-quarter earnings estimates as the Omicron variant curbs the retailer's sales.

The Vancouver-based company says it now expects its net revenue and earnings to be on the low end of previously announced ranges.

Calvin McDonald, CEO of the athletic apparel retailer, says Lululemon started the holiday season in a strong position.

But he says the company has since experienced several consequences as a result of the surge in COVID-19 cases and changing restrictions.

He says Lululemon has been impacted by increased capacity constraints in stores, more limited staff availability and reduced operating hours in some locations.

David Swartz, an equity analyst at Morningstar, says Lululemon has consistently smashed sales and earnings expectations over the past three years, making it surprising to see any weakness emerge.

While he says one mild earnings miss does not materially impact valuation, the financial services firm has long had concerns that Lululemon is significantly overvalued

In a client note last March, Morningstar said Lululemon’s valuation "is as stretched as its leggings."

Lululemon’s share price dropped a little more than six per cent following Monday's announcement, and was down roughly 30 per cent from its all-time high in November.

The company's shares were trading for about US$333.30 midday on the Nasdaq composite. Swartz says Morningstar's fair value estimate is US$193.

Lululemon says it expects the company’s net revenue to be toward the low end of its range of US$2.125 billion to US$2.165 billion.

It expects diluted earnings per share and adjusted diluted earnings per share to be toward the low end of its ranges of US$3.24 to US$3.31 and US$3.25 to US$3.32, respectively.

MORE National ARTICLES

624 COVID19 cases for Thursday

624 COVID19 cases for Thursday
There are 5,929 active cases of COVID-19 in the province and 183,406 people who tested positive have recovered. Of the active cases, 373 individuals are in hospital and 132 are in intensive care. 

624 COVID19 cases for Thursday

No response from PM an 'insult': B.C. First Nation

No response from PM an 'insult': B.C. First Nation
A statement on Thursday from the First Nation in Kamloops, B.C., said the lack of a response to two letters was "an added insult," but it looks forward to welcoming Trudeau in the community later this month.

No response from PM an 'insult': B.C. First Nation

Latest COVID models show B.C. kids most at risk

Latest COVID models show B.C. kids most at risk
The report by 12 epidemiologists, mathematicians and data analysts, from the universities of Victoria and British Columbia, Simon Fraser University and the private sector, covers the period up to Oct. 4.

Latest COVID models show B.C. kids most at risk

B.C. Liberals criticize NDP's fire, heat responses

B.C. Liberals criticize NDP's fire, heat responses
Fraser Nicola Liberal Jackie Tegart says Premier John Horgan's pledge to rebuild the community of Lytton following last June's wildfire that destroyed the community has failed to materialize.    

B.C. Liberals criticize NDP's fire, heat responses

Jagmeet Singh Announces NDP Leadership Roles in the House

Jagmeet Singh Announces NDP Leadership Roles in the House
Today, NDP Leader Jagmeet Singh announced his party’s House Officers and that the NDP caucus has elected veteran MP Jenny Kwan as Caucus Chair and newly-elected MP Blake Desjarlais as Deputy Caucus Chair.

Jagmeet Singh Announces NDP Leadership Roles in the House

Macklem: Need for vaccines in developing nations

Macklem: Need for vaccines in developing nations
Tiff Macklem says the pandemic is not just the biggest health risk facing the world, but also the largest economic risk. In a speech today, he says governments and the private sector must work together to make vaccines available to all.

Macklem: Need for vaccines in developing nations